RE:I thought…The problem is, Kellum told us all on multiple occasions about how flu season was going to increase Tigris enrollment. On multiplce occasions he told us the start date for the DIMI trial.. They talked about DIMI and SAMI as "disruptive technology" only to 180 on that. His "Worst Case" enrollment numbers? Dead wrong.
How many times can he be wrong on the company's most important issues and still be believed?
Not to mention Kellum's 30% qoute which is hard to read as anything but disingenuous..
"Specifically, we added approximately 30% of our total enrollment target in the second half of 2022 alone"